![]() |
市場調查報告書
商品編碼
2102328
居家醫療市場:2034 年區域預測—按服務類型、護理交付模式、技術整合、病患人口統計特徵、支付和報銷模式、最終用戶和地區分類的全球分析Localized Healthcare-at-home Market Forecasts to 2034 - Global Analysis By Service Type, Care Delivery Model, Technology Integration, Patient Demographics, Payment & Reimbursement Model, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球社區居家醫療市場將達到 550 億美元,並在預測期內以 9.0% 的複合年成長率成長,到 2034 年達到 1096 億美元。
社區居家居家醫療利用當地醫療專業人員、數位化解決方案和連網型設備,在個人居住提供醫療服務。這包括遠端醫療、居家診斷、護理服務和持續的病患監測,從而改善醫療服務的可近性並提高便利性。這種方式減少了對醫院的依賴,提高了病患滿意度,並支持長期疾病管理。人口老化、慢性病增加以及遠端醫療技術的進步推動了這一成長。它透過提供個人化、持續性和及時的護理來提高系統效率,同時減輕醫院的負擔。總而言之,它使患者能夠在舒適的家中享受以患者為中心的護理,從而帶來更好的健康結果。
根據聯合國人口基金發布的《2023年印度老化報告》,印度60歲以上人口預計將從2022年的1.49億增加到2050年的3.47億,翻倍。這一年齡層的人群容易患慢性疾病,導致對居家醫療服務的需求增加。
人口老化和慢性病負擔日益加重
人口老化加劇和慢性病發病率上升正顯著推動社區居家居家醫療市場的發展。老年人通常需要定期醫療監督、反覆就診和長期護理,這些服務都可以在家中有效提供。糖尿病、心臟病和肺病等疾病需要持續治療,頻繁的住院治療既費時又昂貴。居家醫療能夠提升老年人的舒適度,減少住院次數,並提供個人化的治療方案。隨著全球預期壽命的延長,人們對便利且價格合理的居家醫療服務的需求日益成長,促使醫療保健機構致力於加強以社區為基礎、以患者為中心的醫療保健服務體系。
熟練人員短缺和協調護理方面的挑戰
社區居家居家醫療市場面臨的主要限制因素之一是合格醫療保健專業人員短缺以及護理協調和管理方面的困難。居家照護依賴護理師和治療師等專業技術人員,但他們的供給往往無法滿足需求。此外,確保醫生、看護者、診斷服務和數位系統之間的順暢協調通常十分複雜,這可能導致護理服務出現缺陷。溝通不良和缺乏標準化標準會影響治療效果。這些問題限制了居家醫療服務的擴充性和一致性,儘管越來越多的患者希望在家中接受醫療服務,但居家醫療保健服務的普及速度仍然緩慢。
遠端醫療和數位醫療生態系統的擴展
遠端醫療和互聯數位醫療系統的蓬勃發展為社區居家醫療市場帶來了巨大的成長機會。線上諮詢、健康應用程式和智慧監測設備的日益普及,使得患者能夠在家中進行持續管理和高效護理。這些解決方案有助於疾病的早期發現,減少對醫院的依賴,並提高病患的治療順從性。人工智慧和數據分析等先進技術則進一步提升了個人化護理和臨床精準度。隨著數位醫療基礎設施投資的增加,醫療服務提供者能夠有效地擴展居家照護,在創造新的商機的同時,也改善了不同社區獲得可靠醫療服務的機會。
誤診風險與緊急應變能力的局限性
社區居家醫療市場面臨的主要挑戰之一是誤診的可能性以及無法有效應對緊急情況。居家醫療和遠端醫療通常缺乏醫院所擁有的先進診斷工具和專家支持,這增加了診斷延誤和不準確的風險。在心臟病發作或嚴重健康併發症等緊急情況下,患者可能無法在家中立即獲得醫療照護。這些限制會削弱患者的信任,並阻礙服務的使用,尤其是在需要持續監測和在設備齊全的醫療機構進行快速醫療干預的嚴重病例中。
新冠疫情推動了居家醫療和遠端醫療服務的需求,在擴大本地居家醫療市場方面發揮了決定性作用。對病毒感染的擔憂、醫院容量的限制以及封鎖措施,促使患者尋求更安全的居家醫療保健方式。隨著遠端醫療的快速普及,醫療服務提供者也擴展了居家診斷、照護支援和復健等服務。疫情危機也加速了對數位健康解決方案和遠端監測技術的投資。因此,患者對居家醫療的信任度和接受度有所提高,使其成為一種可靠且便捷的照護模式,預計即使在疫情結束後,這種需求仍將持續存在。
在預測期內,家庭護理和專業護理行業預計將佔據最大的市場佔有率。
預計在預測期內,居家照護和專業照護產業將佔據最大的市場佔有率,因為它為慢性病患者、術後患者以及有老齡化相關健康需求的人群提供持續的醫療支援。此類別涵蓋藥物管理、傷口護理、健康監測和日常生活支援等服務,這些服務在長期居家照護中發揮著至關重要的作用。老年人口的成長和長期疾病發病率的上升正在推動對可靠、個人化護理解決方案的需求。此外,由於患者傾向於在家中接受專業的醫療支持,從而提高舒適度和促進康復,因此該領域的重要性進一步凸顯。
在預測期內,慢性疾病患者群體預計將呈現最高的複合年成長率。
在預測期內,慢性疾病患者群體預計將呈現最高的成長率,這主要受全球慢性病盛行率不斷上升的推動。糖尿病、心臟病、呼吸系統疾病和高血壓等疾病需要持續後續觀察、定期檢查和持續治療,而這些都可以在家中方便地完成。人們對有效疾病管理的認知不斷提高,以及希望避免頻繁就醫,正在推動居家醫療服務的使用。此外,遠端監測工具和數位醫療解決方案的進步使得持續照護成為可能,讓家庭環境成為有效管理慢性病的理想場所。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其完善的醫療保健體系、數位醫療解決方案的廣泛應用以及眾多主要市場參與企業的存在。該地區的強勁需求預計將受到人口老化和慢性病高發生率(需要長期照護)的推動。支持性的報銷方案和政府計畫正在促進居家醫療服務的普及。此外,患者越來越傾向於在家中接受個人化且便利的治療。遠端醫療和遠距監測技術的應用進一步提升了醫療服務水平,並鞏固了北美在該市場的主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於不斷加快的都市化進程、不斷完善的醫療保健體係以及數位醫療技術的廣泛應用。該地區擁有龐大的人口基數、不斷成長的可支配收入以及人們對居家醫療服務日益成長的認知。各國政府和私人企業正在投資遠端醫療、遠端患者監護和社區護理項目,以改善醫療保健服務的可近性。慢性疾病患者數量的增加和人口老化也推動了持續居家照護需求的成長。這些因素共同促成了亞太地區成為社區醫療保健服務領域領先的高成長市場。
According to Stratistics MRC, the Global Localized Healthcare-at-home Market is accounted for $55.0 billion in 2026 and is expected to reach $109.6 billion by 2034 growing at a CAGR of 9.0% during the forecast period. Localized healthcare-at-home involves providing medical care to individuals in their residences using local healthcare professionals, digital solutions, and connected devices. It covers telemedicine, in-home diagnostics, nursing services, and ongoing patient monitoring, making care more accessible and convenient. This approach reduces reliance on hospitals, enhances patient satisfaction, and supports long-term condition management. Growth is driven by an aging population, increasing chronic diseases, and technological progress in remote healthcare. It improves system efficiency by easing hospital pressure while delivering customized, consistent, and prompt care. Overall, it enables patient-centric treatment in a comfortable home setting with better health outcomes.
According to the India Ageing Report 2023 (UNFPA), India's population aged 60+ will double from 149 million in 2022 to 347 million by 2050. This demographic is highly susceptible to chronic diseases, creating strong demand for home healthcare services.
Rising aging population and chronic disease burden
The expansion of the elderly population along with the rising incidence of chronic illnesses significantly drives the localized healthcare-at-home market. Older adults typically need regular medical supervision, repeated consultations, and extended care, which can be efficiently provided in home settings. Diseases such as diabetes, heart conditions, and lung disorders require continuous attention, making frequent hospital visits challenging and expensive. Home healthcare enhances comfort, minimizes hospital admissions, and delivers tailored treatment. With increasing global life expectancy, the need for convenient and affordable in-home medical services is rising, motivating providers to strengthen localized and patient-focused healthcare delivery systems.
Limited skilled workforce and care coordination challenges
One major limitation of the localized healthcare-at-home market is the inadequate availability of qualified healthcare personnel along with difficulties in managing coordinated care. Home-based treatment depends on skilled professionals such as nurses and therapists, yet supply frequently falls short of demand. Moreover, ensuring smooth coordination among doctors, caregivers, diagnostic services, and digital systems is often complicated, which can result in gaps in care delivery. Poor communication and absence of uniform standards may affect treatment effectiveness. These issues restrict the scalability and consistency of in-home healthcare services, slowing adoption even as more patients prefer receiving medical care at home.
Expansion of telehealth and digital care ecosystems
The growth of telemedicine and interconnected digital healthcare systems offers a major opportunity for the localized healthcare-at-home market. The rising use of virtual consultations, health apps, and smart monitoring devices allows continuous patient supervision and efficient care delivery at home. These solutions help in early detection of illnesses, minimize hospital dependency, and improve patient compliance with treatments. Advanced technologies like artificial intelligence and data analytics strengthen personalized care and clinical accuracy. With increasing investments in digital healthcare infrastructure, providers can expand home-based services effectively, creating new business opportunities while enhancing access to reliable medical care in diverse regions.
Risk of misdiagnosis and limited emergency response capability
One key threat facing the localized healthcare-at-home market is the possibility of incorrect diagnosis and the inability to effectively manage emergencies. Home-based and virtual care often do not have the advanced diagnostic tools and specialist support found in hospitals, increasing the risk of delayed or inaccurate assessments. In urgent situations like heart attacks or severe health complications, immediate medical attention may not be readily available at home. Such limitations can lower patient trust and discourage adoption, particularly for serious conditions that require continuous supervision and quick medical intervention in fully equipped healthcare facilities.
The outbreak of COVID-19 played a crucial role in boosting the localized healthcare-at-home market by driving the need for in-home and remote healthcare services. Concerns about virus transmission, overwhelmed hospitals, and lockdown measures pushed patients toward safer care options at home. The use of telemedicine increased rapidly, while providers expanded services such as home diagnostics, nursing support, and recovery care. The crisis also accelerated investments in digital health solutions and remote monitoring technologies. As a result, patient trust and acceptance of home healthcare improved, positioning it as a dependable and convenient care model with sustained demand even after the pandemic.
The home nursing & skilled care segment is expected to be the largest during the forecast period
The home nursing & skilled care segment is expected to account for the largest market share during the forecast period because it delivers ongoing medical assistance to individuals with chronic diseases, post-operative conditions, and age-related health needs. This category includes services such as medication management, wound treatment, health monitoring, and support with everyday tasks, making it crucial for extended home-based care. The increasing elderly population and higher incidence of long-term illnesses are boosting demand for dependable and tailored care solutions. Moreover, patients favor receiving skilled medical support at home, improving comfort and recovery, which strengthens the prominence of this segment.
The chronic disease patients segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the chronic disease patients segment is predicted to witness the highest growth rate, driven by the increasing prevalence of long-term medical conditions worldwide. Conditions like diabetes, heart diseases, respiratory disorders, and high blood pressure require consistent supervision, periodic consultations, and sustained treatment, which can be conveniently provided at home. Growing awareness about effective disease control and the desire to avoid frequent hospital visits are promoting the use of home healthcare services. Furthermore, improvements in remote monitoring tools and digital healthcare solutions enable continuous care, making home-based settings highly suitable for managing chronic diseases effectively.
During the forecast period, the North America region is expected to hold the largest market share, owing to its well-developed healthcare system, widespread use of digital health solutions, and the presence of major industry participants. The region experiences strong demand driven by an aging population and a high incidence of chronic illnesses requiring long-term care. Supportive reimbursement frameworks and government programs promote the adoption of home healthcare services. Moreover, patients increasingly prefer personalized and convenient treatment at home. The use of telemedicine and remote monitoring technologies further enhances care delivery, reinforcing North America's leading position in this market.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, supported by urban growth, improving healthcare systems, and rising use of digital medical technologies. The region benefits from a large population base, increasing disposable incomes, and greater awareness of in-home healthcare services. Governments and private players are investing in telemedicine, remote patient monitoring, and community care programs to improve healthcare access. A growing number of chronic disease cases and an aging population are also contributing to higher demand for continuous home-based care. These factors collectively position Asia-Pacific as a major high-growth market for localized healthcare services.
Key players in the market
Some of the key players in Localized Healthcare-at-home Market include Medically Home, Contessa Health, DispatchHealth, AlayaCare, Heal, Amedisys, AccentCare, Bayada Home Health Care, LHC Group, Signify Health, ResMed, Fresenius Medical Care, Koninklijke Philips N.V., GE Healthcare, Stryker, Amwell, Peerbridge and Casana.
In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc, to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women's health.
In September 2025, Stryker and Siemens Healthineers announced a strategic partnership in the field of neurovascular robotics. The collaboration aims to develop a unique robotic system capable of performing a comprehensive range of elective and emergency neurovascular procedures, including treatment for strokes and aneurysms.
In May 2025, Resmed announced that it acquired VirtuOx, a leading independent diagnostic testing facility (IDTF). VirtuOx provides diagnostic services for sleep, respiratory and cardiac conditions. San Diego-based Resmed, a leader in sleep apnea therapy and digital offerings, says the acquisition reflects its commitment to making care more accessible, more coordinated and more patient-friendly.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.